ATE407149T1 - Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente - Google Patents

Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente

Info

Publication number
ATE407149T1
ATE407149T1 AT97930416T AT97930416T ATE407149T1 AT E407149 T1 ATE407149 T1 AT E407149T1 AT 97930416 T AT97930416 T AT 97930416T AT 97930416 T AT97930416 T AT 97930416T AT E407149 T1 ATE407149 T1 AT E407149T1
Authority
AT
Austria
Prior art keywords
drugs
fragments
detoxification
administered intramuscularly
animals treated
Prior art date
Application number
AT97930416T
Other languages
English (en)
Inventor
Ivo Volpato
Bernard Bizzini
Ernst Grabitz
Original Assignee
Dox Al Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dox Al Italia Spa filed Critical Dox Al Italia Spa
Application granted granted Critical
Publication of ATE407149T1 publication Critical patent/ATE407149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97930416T 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente ATE407149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001309A IT1284076B1 (it) 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro

Publications (1)

Publication Number Publication Date
ATE407149T1 true ATE407149T1 (de) 2008-09-15

Family

ID=11374491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930416T ATE407149T1 (de) 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente

Country Status (6)

Country Link
EP (1) EP0934339B1 (de)
AT (1) ATE407149T1 (de)
AU (1) AU3437497A (de)
DE (1) DE69738965D1 (de)
IT (1) IT1284076B1 (de)
WO (1) WO1997049732A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
WO2001081424A1 (en) * 2000-04-20 2001-11-01 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US6669937B2 (en) * 2000-04-20 2003-12-30 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US7632929B2 (en) 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
ITMI20010347A1 (it) 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
EP1331219A1 (de) * 2002-01-23 2003-07-30 Drug Abuse Sciences, Inc. Neue Amphetaminderivate, dagegen gerichtete Antikörper und diese enthaltende pharmazeutische Zusammensetzungen
ES2415655T3 (es) 2006-06-15 2013-07-26 The Board Of Trustees Of The University Of Arkansas Anticuerpos monoclonales que reconocen selectivamente Metanfetamina y compuestos similares a Metanfetamina
US8853146B2 (en) 2007-04-20 2014-10-07 The Board Of Trustees Of The University Of Arkansas Hapten compounds and compositions and uses thereof
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN111060690B (zh) * 2019-10-08 2023-07-07 浙江工商大学 一种检测喹乙醇的时间分辨荧光免疫分析试剂盒及其应用
CN111154000A (zh) * 2020-01-16 2020-05-15 新乡学院 一种抗西马特罗单克隆抗体及其应用
CN111269319B (zh) * 2020-02-21 2021-10-29 华南农业大学 一种特异性纳米抗体Nb2F7及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol

Also Published As

Publication number Publication date
IT1284076B1 (it) 1998-05-08
ITMI961309A1 (it) 1997-12-27
WO1997049732A1 (en) 1997-12-31
DE69738965D1 (de) 2008-10-16
EP0934339A1 (de) 1999-08-11
ITMI961309A0 (de) 1996-06-27
EP0934339B1 (de) 2008-09-03
AU3437497A (en) 1998-01-14

Similar Documents

Publication Publication Date Title
ATE280783T1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
ATE407149T1 (de) Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente
ATE512224T1 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
KR950005327A (ko) 임파구 항원 CD2 및 종양 항원을 인식하는 이특이적 트리거(Trigger) 분자
LU93274I2 (fr) Elotuzumab
EP0671920A4 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten.
DE69932084D1 (de) Antikörperfragmente zur lokalen Behandlung von Augenerkrankungen
ATE212038T1 (de) Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung
KR900005995A (ko) 변형 인터류킨-2 및 그의 제조방법
CY1109817T1 (el) Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου
ATE128627T1 (de) Immunomodulare mittel und deren verwendung.
DK0433088T3 (da) Monoklonale antistoffer, der reagerer med et humant atheromaassocieret antigen
NO873495D0 (no) Monoklonale antistoffer og peptider egnet for behandling og diagnose av hiv-infeksjoner.
DK0744957T3 (da) Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A
Sandberg et al. Initiation of bone resorption by the classical and alternative C pathways and its mediation by prostaglandins
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ATE484294T1 (de) Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
GEP20002257B (en) Method for Reducing Fibrin Accumulation Speed, Prophylactics of Thrombus Complications and Treatment of Blood Vessels Diseases, Medicinal Composition and Medicinal Species
DE69030545D1 (de) Aufspüren und Behandeln von Infektionen durch Verwendung von Immunokonjukaten
DE69636527D1 (de) Antigenes protein aus malassezia
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
KR910006478A (ko) 인체 트립타제 유사 단백질
Rangel-Santos et al. Effect of heating on the toxic, immunogenic and immunosuppressive activities of Crotalus durissus terrificus venom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties